Fig. 2From: Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomesComparisons poractant-α vs bovine surfactants for NICU length of stay. The panel (855 patients) illustrates meta-analyses of any dose of poractant-α vs bovine surfactants with random-effects model. Poractant-α and bovine surfactants are considered as treatment and control arm, respectively; mean differences (95%CI) in NICU stay are reported (in days). Squares and horizontal lines represent mean differences in NICU stay (expressed in days) and their 95%CI, respectively. The location of the diamond and its width represent the pooled estimated effect size and its 95%CI, respectivelyBack to article page